Haplotyping analyses on disease susceptibility genes in urogenital cancer: The application for ordermade care

A. Yokomizo, H. Koga, M. Nakashima, S. Naito, H. Noma, A. Yamaguchi

Research output: Contribution to journalArticle

Abstract

Variations in cancer-causative genes are potentially associated with high-risk groups of the disease. We hypothesized that Luteinizing hormone β, CYP17, Glutathione S-transferase (GST) P1, M1, T1 and insulin-like growth factor 1 receptor (IGF1R) are prostate cancer susceptibility molecules. We determined the distributions of polymorphisms in these genes in Caucasian familial prostate cancer patients (n=171), an age- and race-matched control group (n=144) and in Japanese prostate cancer patients (n=68), and a matched control group (n=126). We observed a significantly higher frequency of variant type of LHβ only in Caucasians, and not in Japanese. Furthermore, we found a significantly higher frequency of polymorphic valine105 in the GSTP1 gene both in Caucasians and in Japanese. Our results indicate that the genetic variants of LHβ and GSTP1 have some significance in the predisposition of prostate cancer in each population, and that these markers could be useful for predicting the prostate cancer risk of individuals.

Original languageEnglish
Pages (from-to)309-313
Number of pages5
JournalNishinihon Journal of Urology
Volume63
Issue number5
Publication statusPublished - Jan 1 2001

Fingerprint

Urogenital Neoplasms
Disease Susceptibility
Prostatic Neoplasms
Genes
Research Design
Steroid 17-alpha-Hydroxylase
Somatomedin Receptors
Control Groups
Neoplasm Genes
Luteinizing Hormone
Population

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Yokomizo, A., Koga, H., Nakashima, M., Naito, S., Noma, H., & Yamaguchi, A. (2001). Haplotyping analyses on disease susceptibility genes in urogenital cancer: The application for ordermade care. Nishinihon Journal of Urology, 63(5), 309-313.

Haplotyping analyses on disease susceptibility genes in urogenital cancer : The application for ordermade care. / Yokomizo, A.; Koga, H.; Nakashima, M.; Naito, S.; Noma, H.; Yamaguchi, A.

In: Nishinihon Journal of Urology, Vol. 63, No. 5, 01.01.2001, p. 309-313.

Research output: Contribution to journalArticle

Yokomizo, A, Koga, H, Nakashima, M, Naito, S, Noma, H & Yamaguchi, A 2001, 'Haplotyping analyses on disease susceptibility genes in urogenital cancer: The application for ordermade care', Nishinihon Journal of Urology, vol. 63, no. 5, pp. 309-313.
Yokomizo A, Koga H, Nakashima M, Naito S, Noma H, Yamaguchi A. Haplotyping analyses on disease susceptibility genes in urogenital cancer: The application for ordermade care. Nishinihon Journal of Urology. 2001 Jan 1;63(5):309-313.
Yokomizo, A. ; Koga, H. ; Nakashima, M. ; Naito, S. ; Noma, H. ; Yamaguchi, A. / Haplotyping analyses on disease susceptibility genes in urogenital cancer : The application for ordermade care. In: Nishinihon Journal of Urology. 2001 ; Vol. 63, No. 5. pp. 309-313.
@article{035d8830954440ff803d797571392803,
title = "Haplotyping analyses on disease susceptibility genes in urogenital cancer: The application for ordermade care",
abstract = "Variations in cancer-causative genes are potentially associated with high-risk groups of the disease. We hypothesized that Luteinizing hormone β, CYP17, Glutathione S-transferase (GST) P1, M1, T1 and insulin-like growth factor 1 receptor (IGF1R) are prostate cancer susceptibility molecules. We determined the distributions of polymorphisms in these genes in Caucasian familial prostate cancer patients (n=171), an age- and race-matched control group (n=144) and in Japanese prostate cancer patients (n=68), and a matched control group (n=126). We observed a significantly higher frequency of variant type of LHβ only in Caucasians, and not in Japanese. Furthermore, we found a significantly higher frequency of polymorphic valine105 in the GSTP1 gene both in Caucasians and in Japanese. Our results indicate that the genetic variants of LHβ and GSTP1 have some significance in the predisposition of prostate cancer in each population, and that these markers could be useful for predicting the prostate cancer risk of individuals.",
author = "A. Yokomizo and H. Koga and M. Nakashima and S. Naito and H. Noma and A. Yamaguchi",
year = "2001",
month = "1",
day = "1",
language = "English",
volume = "63",
pages = "309--313",
journal = "Nishinihon Journal of Urology",
issn = "0029-0726",
publisher = "Kyushu University, Faculty of Science",
number = "5",

}

TY - JOUR

T1 - Haplotyping analyses on disease susceptibility genes in urogenital cancer

T2 - The application for ordermade care

AU - Yokomizo, A.

AU - Koga, H.

AU - Nakashima, M.

AU - Naito, S.

AU - Noma, H.

AU - Yamaguchi, A.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Variations in cancer-causative genes are potentially associated with high-risk groups of the disease. We hypothesized that Luteinizing hormone β, CYP17, Glutathione S-transferase (GST) P1, M1, T1 and insulin-like growth factor 1 receptor (IGF1R) are prostate cancer susceptibility molecules. We determined the distributions of polymorphisms in these genes in Caucasian familial prostate cancer patients (n=171), an age- and race-matched control group (n=144) and in Japanese prostate cancer patients (n=68), and a matched control group (n=126). We observed a significantly higher frequency of variant type of LHβ only in Caucasians, and not in Japanese. Furthermore, we found a significantly higher frequency of polymorphic valine105 in the GSTP1 gene both in Caucasians and in Japanese. Our results indicate that the genetic variants of LHβ and GSTP1 have some significance in the predisposition of prostate cancer in each population, and that these markers could be useful for predicting the prostate cancer risk of individuals.

AB - Variations in cancer-causative genes are potentially associated with high-risk groups of the disease. We hypothesized that Luteinizing hormone β, CYP17, Glutathione S-transferase (GST) P1, M1, T1 and insulin-like growth factor 1 receptor (IGF1R) are prostate cancer susceptibility molecules. We determined the distributions of polymorphisms in these genes in Caucasian familial prostate cancer patients (n=171), an age- and race-matched control group (n=144) and in Japanese prostate cancer patients (n=68), and a matched control group (n=126). We observed a significantly higher frequency of variant type of LHβ only in Caucasians, and not in Japanese. Furthermore, we found a significantly higher frequency of polymorphic valine105 in the GSTP1 gene both in Caucasians and in Japanese. Our results indicate that the genetic variants of LHβ and GSTP1 have some significance in the predisposition of prostate cancer in each population, and that these markers could be useful for predicting the prostate cancer risk of individuals.

UR - http://www.scopus.com/inward/record.url?scp=0035014804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035014804&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0035014804

VL - 63

SP - 309

EP - 313

JO - Nishinihon Journal of Urology

JF - Nishinihon Journal of Urology

SN - 0029-0726

IS - 5

ER -